NEXGEL (NXGLW) Competitors $0.90 +0.09 (+11.10%) (As of 10:49 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NXGLW vs. DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, LUCYW, IINNW, and NVACWShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), and NorthView Acquisition (NVACW). These companies are all part of the "medical equipment" industry. NEXGEL vs. Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NorthView Acquisition Alpha Tau Medical (NASDAQ:DRTSW) and NEXGEL (NASDAQ:NXGLW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Is DRTSW or NXGLW more profitable? Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A N/A N/A NEXGEL N/A N/A N/A Does the MarketBeat Community prefer DRTSW or NXGLW? Alpha Tau Medical and NEXGEL both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlpha Tau MedicalN/AN/ANEXGELN/AN/A Does the media prefer DRTSW or NXGLW? In the previous week, Alpha Tau Medical had 2 more articles in the media than NEXGEL. MarketBeat recorded 2 mentions for Alpha Tau Medical and 0 mentions for NEXGEL. Alpha Tau Medical's average media sentiment score of 0.92 beat NEXGEL's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media. Company Overall Sentiment Alpha Tau Medical Positive NEXGEL Neutral Which has preferable valuation & earnings, DRTSW or NXGLW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/AN/AN/AN/ANEXGEL$6.73MN/AN/AN/AN/A SummaryAlpha Tau Medical beats NEXGEL on 2 of the 3 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGLW vs. The Competition Export to ExcelMetricNEXGELMedical Instruments & Supplies IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.40B$5.14B$9.30BDividend YieldN/A2.01%4.81%4.06%P/E RatioN/A310.72135.3017.49Price / SalesN/A188.411,186.56136.36Price / CashN/A121.9040.4237.95Price / BookN/A2.814.874.92Net IncomeN/A$84.03M$118.61M$225.42M7 Day Performance40.61%-0.92%15.32%-1.20%1 Month Performance79.98%-0.50%15.26%7.09%1 Year Performance83.65%-4.65%34.42%22.83% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLWNEXGELN/A$0.90+11.1%N/AN/A$0.00$6.73M0.0010Positive NewsDRTSWAlpha Tau MedicalN/A$0.20-21.3%N/A+4.1%$0.00N/A0.0080News CoverageGap UpANZUWAnzu Special Acquisition Corp IN/A$0.09-1.1%N/A+561.8%$0.00N/A0.002Gap DownBBLGWBone BiologicsN/A$27.80flatN/A+3,761.1%$0.00N/A0.002Positive NewsBRSHWBruush Oral CareN/A$0.01-1.8%N/AN/A$0.00$2.92M0.0011Gap UpGMVDWG Medical InnovationsN/A$6.90+26.4%N/AN/A$0.00$4.42M0.0072Gap UpHSCSWHeart Test LaboratoriesN/A$0.04+32.9%N/AN/A$0.00$18,600.000.0010News CoveragePositive NewsGap UpBEATWHeartBeamN/A$0.80-15.8%N/AN/A$0.00N/A0.005Positive NewsLUCYWInnovative EyewearN/A$0.05+2.3%N/AN/A$0.00$1.56M0.009Positive NewsGap UpIINNWInspira Technologies Oxy B.H.N.N/A$0.29+18.4%N/A+76.9%$0.00N/A0.0020News CoveragePositive NewsGap DownNVACWNorthView AcquisitionN/A$0.04-20.5%N/AN/A$0.00N/A0.002Positive NewsGap Down Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives G Medical Innovations Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Inspira Technologies Oxy B.H.N. Alternatives NorthView Acquisition Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXGLW) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.